Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.43 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9716842 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL2345422 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL9716734 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL1532638 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL9314956 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL9716836 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL9716728 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL9716750 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL21838291 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL3245095 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024229256-A1 | METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS | GLO PHARMA, INC. (US) | 2024-11-07 | — | — | WO | claimed |
| EP-4426263-A2 | METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS | GLO Pharma, Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| EP-4314013-A1 | MULTISOME LIPID VESICLES FOR DELIVERY OF COSMETIC AGENTS | GLO Pharma, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| EP-4313100-A2 | PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION | GLO Pharma, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| WO-2023081259-A2 | METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS | GLO PHARMA, INC. (US) | 2023-05-11 | — | — | WO | claimed |
| WO-2022204305-A2 | PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION | GLO PHARMA, INC. (US) | 2022-09-29 | — | — | WO | claimed |
| WO-2022204308-A1 | MULTISOME LIPID VESICLES FOR DELIVERY OF COSMETIC AGENTS | GLO PHARMA, INC. (US) | 2022-09-29 | — | — | WO | claimed |
| EP-1150995-B1 | A SYNTHETIC PEPTIDE DISTURBING INTRACELLULAR SIGNALING | BUKWANG PHARMACEUTICAL CO LTD (KR) | 2006-01-04 | — | — | EP | claimed |
| EP-1575617-A1 | USE OF TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING AN ACTIVE AGENT AND PERMEATION-ENHANCING BASE FOR THE MANUFACTURE OF A MEDICAMENT TO TREAT VARIOUS FORMS OF INFLAMMATORY DERMATOSIS | Dermatrends, Inc. (US) | 2005-09-21 | — | — | EP | claimed |
| EP-1558228-A1 | TOPICAL ADMINISTRATION OF BASIC ANTIFUNGAL COMPOSITIONS TO TREAT FUNGAL INFECTIONS OF THE NAILS | Dermatrends, Inc. (US) | 2005-08-03 | — | — | EP | claimed |
| US-20030099678-A1 | Method and topical formulation for treating skin conditions associated with aging | TECHNOLOGY RECOVERY SYSTEMS, LLC | 2003-05-29 | — | — | US | claimed |
| US-20030077301-A1 | Topical pharmaceutical composition for the treatment of inflammatory dermatoses | DERMATRENDS, INC. | 2003-04-24 | — | — | US | claimed |
| US-20030072814-A1 | Topical pharmaceutical composition for the treatment of warts | DERMATRENDS, INC. | 2003-04-17 | — | — | US | claimed |
| US-20030072724-A1 | Topical pharmaceutical composition to treat hyperpigmentation of the skin | MAIBACH HOWARD I (US) | 2003-04-17 | — | — | US | claimed |
| WO-2003026680-A2 | METHOD AND TOPICAL FORMULATION FOR TREATING SKIN CONDITIONS ASSOCIATED WITH AGING | DERMATRENDS, INC. (US) | 2003-04-03 | — | — | WO | claimed |
| US-20030059450-A1 | Method and topical formulation for treating skin conditions associated with aging | MAIBACH HOWARD I (US) | 2003-03-27 | — | — | US | claimed |
| EP-1150995-A1 | A SYNTHETIC PEPTIDE DISTURBING INTRACELLULAR SIGNALING | Yoon, Jeong Hyeok (KR) | 2001-11-07 | — | — | EP | claimed |
| WO-2000047607-A1 | A SYNTHETIC PEPTIDE DISTURBING INTRACELLULAR SIGNALING | YOON JEONG HYEOK (KR) | 2000-08-17 | — | — | WO | claimed |
| US-5853755-A | Biphasic multilamellar lipid vesicles | PHARMADERM LABORATORIES LTD. (CA) | 1998-12-29 | — | — | US | claimed |
| WO-1992000098-A1 | METHODS OF INDUCING IMMUNE RESPONSE TO AIDS VIRUS | ZAGURY DANIEL (FR) | 1992-01-09 | — | — | WO | claimed |